Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1993 Jul;48(7):730–735. doi: 10.1136/thx.48.7.730

Atrial natriuretic peptide in stable and decompensated chronic obstructive pulmonary disease.

K Skwarski 1, M Lee 1, L Turnbull 1, W MacNee 1
PMCID: PMC464658  PMID: 8153922

Abstract

BACKGROUND--Plasma levels of atrial natriuretic peptide (ANP) are elevated in patients with chronic obstructive pulmonary disease (COPD) and may have a role in preventing oedema formation in these patients. METHODS--Plasma ANP levels were measured in 60 patients with COPD and these measurements were related to pulmonary haemodynamics, response to treatment during exacerbations, and clinical patterns of the stable disease. RESULTS--Plasma ANP levels did not correlate significantly with right atrial or pulmonary arterial pressures but did correlate significantly with both the right ventricular end diastolic volume and right ventricular wall volume measured by magnetic resonance imaging. Oxygen (2 1/min by nasal prongs for 30 minutes) did not change the mean pulmonary arterial pressure or the level of plasma ANP. In 20 patients with an acute exacerbation of COPD plasma ANP levels were higher in those with oedema (302 (185) pg/ml) than in those without oedema (87 (43) pg/ml). Oxygen given for one hour had no effect on plasma levels of ANP. However, plasma ANP levels fell over the first three days during treatment in those with oedema, the fall correlating with the change in body weight. In a further 20 stable patients with hypoxic COPD, those with hypercapnia and previous episodes of oedema had higher levels of plasma ANP (120 (50) pg/ml) than normocapnic patients with no previous oedema (54 (15) pg/ml). CONCLUSIONS--The level of ANP is high in the plasma of patients with COPD, particularly during exacerbations in those with oedema. The association of a high plasma ANP level and volume overload is shown by the fall in ANP levels with treatment of the oedema, and the correlation between levels of ANP and right ventricular end diastolic or wall volumes.

Full text

PDF
730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham A. S., Cole R. B., Green I. D., Hedworth-Whitty R. B., Clarke S. W., Bishop J. M. Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res. 1969 Jan;24(1):51–60. doi: 10.1161/01.res.24.1.51. [DOI] [PubMed] [Google Scholar]
  2. Adnot S., Andrivet P., Chabrier P. E., Piquet J., Plas P., Braquet P., Roudot-Thoraval F., Brun-Buisson C. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. Physiological correlates and response to peptide infusion. J Clin Invest. 1989 Mar;83(3):986–993. doi: 10.1172/JCI113985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adnot S., Chabrier P. E., Andrivet P., Viossat I., Piquet J., Brun-Buisson C., Gutkowska Y., Braquet P. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis. 1987 Oct;136(4):951–956. doi: 10.1164/ajrccm/136.4.951. [DOI] [PubMed] [Google Scholar]
  4. Au J., Brown J. E., Lee M. R., Boon N. A. Effect of cardiac tamponade on atrial natriuretic peptide concentrations: influence of stretch and pressure. Clin Sci (Lond) 1990 Oct;79(4):377–380. doi: 10.1042/cs0790377. [DOI] [PubMed] [Google Scholar]
  5. Au J., Brown J. E., Lee M. R., Boon N. A. Effect of cardiac tamponade on atrial natriuretic peptide concentrations: influence of stretch and pressure. Clin Sci (Lond) 1990 Oct;79(4):377–380. doi: 10.1042/cs0790377. [DOI] [PubMed] [Google Scholar]
  6. Burghuber O. C., Hartter E., Punzengruber C., Weissel M., Woloszczuk W. Human atrial natriuretic peptide secretion in precapillary pulmonary hypertension. Clinical study in patients with COPD and interstitial fibrosis. Chest. 1988 Jan;93(1):31–37. doi: 10.1378/chest.93.1.31. [DOI] [PubMed] [Google Scholar]
  7. Campbell R. H., Brand H. L., Cox J. R., Howard P. Body weight and body water in chronic cor pulmonale. Clin Sci Mol Med. 1975 Oct;49(4):323–335. doi: 10.1042/cs0490323. [DOI] [PubMed] [Google Scholar]
  8. Carlone S., Palange P., Mannix E. T., Salatto M. P., Serra P., Weinberger M. H., Aronoff G. R., Cockerill E. M., Manfredi F., Farber M. O. Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure. Am J Med Sci. 1989 Oct;298(4):243–248. doi: 10.1097/00000441-198910000-00006. [DOI] [PubMed] [Google Scholar]
  9. Colice G. L., Farber M., Rose C. E., Jr, Raff H., Ramirez G. Fluid balance in acute and chronic lung disease. Am Rev Respir Dis. 1988 Oct;138(4):1052–1053. [PubMed] [Google Scholar]
  10. Espiner E. A., Richards A. M. Atrial natriuretic peptide. An important factor in sodium and blood pressure regulation. Lancet. 1989 Apr 1;1(8640):707–710. doi: 10.1016/s0140-6736(89)92217-4. [DOI] [PubMed] [Google Scholar]
  11. Farber M. O., Bright T. P., Strawbridge R. A., Robertson G. L., Manfredi F. Impaired water handling in chronic obstructive lung disease. J Lab Clin Med. 1975 Jan;85(1):41–49. [PubMed] [Google Scholar]
  12. Farber M. O., Roberts L. R., Weinberger M. H., Robertson G. L., Fineberg N. S., Manfredi F. Abnormalities of sodium and H2O handling in chronic obstructive lung disease. Arch Intern Med. 1982 Jul;142(7):1326–1330. [PubMed] [Google Scholar]
  13. Fishman A. P. State of the art: chronic cor pulmonale. Am Rev Respir Dis. 1976 Oct;114(4):775–794. doi: 10.1164/arrd.1976.114.4.775. [DOI] [PubMed] [Google Scholar]
  14. Freestone S., MacDonald T. M., Jeffrey R. F., Brown J., Lee M. R. The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride. Br J Clin Pharmacol. 1989 Jan;27(1):13–18. doi: 10.1111/j.1365-2125.1989.tb05329.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hartter E., Weissel M., Stummvoll H. K., Woloszczuk W., Punzengruber C., Ludvik B. Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure. Lancet. 1985 Jul 13;2(8446):93–94. doi: 10.1016/s0140-6736(85)90193-x. [DOI] [PubMed] [Google Scholar]
  16. Hartter E., Woloszczuk W., Stummvoll H. K. Radioimmunoassay of atrial natriuretic peptides in human plasma. Clin Chem. 1986 Mar;32(3):441–445. [PubMed] [Google Scholar]
  17. Lang R. E., Thölken H., Ganten D., Luft F. C., Ruskoaho H., Unger T. Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature. 1985 Mar 21;314(6008):264–266. doi: 10.1038/314264a0. [DOI] [PubMed] [Google Scholar]
  18. Laragh J. H., Cody R. J., Covit A. B., Atlas S. A. The renin system and atrial natriuretic hormone in congestive heart failure. Acta Med Scand Suppl. 1986;707:45–53. doi: 10.1111/j.0954-6820.1986.tb18114.x. [DOI] [PubMed] [Google Scholar]
  19. MacNee W., Wathen C. G., Flenley D. C., Muir A. D. The effects of controlled oxygen therapy on ventricular function in patients with stable and decompensated cor pulmonale. Am Rev Respir Dis. 1988 Jun;137(6):1289–1295. doi: 10.1164/ajrccm/137.6.1289. [DOI] [PubMed] [Google Scholar]
  20. MacNee W., Xue Q. F., Hannan W. J., Flenley D. C., Adie C. J., Muir A. L. Assessment by radionuclide angiography of right and left ventricular function in chronic bronchitis and emphysema. Thorax. 1983 Jul;38(7):494–500. doi: 10.1136/thx.38.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mannix E. T., Dowdeswell I., Carlone S., Palange P., Aronoff G. R., Farber M. O. The effect of oxygen on sodium excretion in hypoxemic patients with chronic obstructive lung disease. Chest. 1990 Apr;97(4):840–844. doi: 10.1378/chest.97.4.840. [DOI] [PubMed] [Google Scholar]
  22. Raffestin B., Adnot S., Mercadier J. J., Levame M., Duc P., Braquet P., Viossat I., Chabrier P. E. Synthesis and secretion of atrial natriuretic factor during chronic hypoxia: a study in the conscious instrumented rat. Clin Sci (Lond) 1990 Jun;78(6):597–603. doi: 10.1042/cs0780597. [DOI] [PubMed] [Google Scholar]
  23. Raine A. E., Erne P., Bürgisser E., Müller F. B., Bolli P., Burkart F., Bühler F. R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med. 1986 Aug 28;315(9):533–537. doi: 10.1056/NEJM198608283150901. [DOI] [PubMed] [Google Scholar]
  24. Reihman D. H., Farber M. O., Weinberger M. H., Henry D. P., Fineberg N. S., Dowdeswell I. R., Burt R. W., Manfredi F. Effect of hypoxemia on sodium and water excretion in chronic obstructive lung disease. Am J Med. 1985 Jan;78(1):87–94. doi: 10.1016/0002-9343(85)90467-x. [DOI] [PubMed] [Google Scholar]
  25. Richards A. M., Nicholls M. G., Ikram H., Webster M. W., Yandle T. G., Espiner E. A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. doi: 10.1016/s0140-6736(85)91207-3. [DOI] [PubMed] [Google Scholar]
  26. Richards A. M., Tonolo G., Polonia J., Montorsi P. Contrasting plasma atrial natriuretic factor concentrations during comparable natriuresis with infusions of atrial natriuretic factor and saline in normal man. Clin Sci (Lond) 1988 Nov;75(5):455–462. doi: 10.1042/cs0750455. [DOI] [PubMed] [Google Scholar]
  27. Richens J. M., Howard P. Oedema in cor pulmonale. Clin Sci (Lond) 1982 Mar;62(3):255–259. doi: 10.1042/cs0620255. [DOI] [PubMed] [Google Scholar]
  28. Shenker Y., Sider R. S., Ostafin E. A., Grekin R. J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest. 1985 Oct;76(4):1684–1687. doi: 10.1172/JCI112154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith M. A., Ridgway J. P., Brydon J. W., Been M., Douglas R. H., Kean D. M., Muir A. L., Best J. J. ECG-gated T1 images of the heart. Phys Med Biol. 1986 Jul;31(7):771–778. doi: 10.1088/0031-9155/31/7/007. [DOI] [PubMed] [Google Scholar]
  30. Turnbull L. W., Ridgway J. P., Biernacki W., McRitchie H., Muir A. L., Best J. J., MacNee W. Assessment of the right ventricle by magnetic resonance imaging in chronic obstructive lung disease. Thorax. 1990 Aug;45(8):597–601. doi: 10.1136/thx.45.8.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Weitzenblum E., Sautegeau A., Ehrhart M., Mammosser M., Hirth C., Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984 Dec;130(6):993–998. doi: 10.1164/arrd.1984.130.6.993. [DOI] [PubMed] [Google Scholar]
  32. Wilkinson M., Langhorne C. A., Heath D., Barer G. R., Howard P. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med. 1988 Jan;66(249):65–85. [PubMed] [Google Scholar]
  33. Winter R. J., Davidson A. C., Treacher D., Rudd R. M., Anderson J. V., Meleagros L., Bloom S. R. Atrial natriuretic peptide concentrations in hypoxic secondary pulmonary hypertension: relation to haemodynamic and blood gas variables and response to supplemental oxygen. Thorax. 1989 Jan;44(1):58–62. doi: 10.1136/thx.44.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Xue Q. F., MacNee W., Flenley D. C., Hannan W. J., Adie C. J., Muir A. L. Can right ventricular performance be assessed by equilibrium radionuclide ventriculography? Thorax. 1983 Jul;38(7):486–493. doi: 10.1136/thx.38.7.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES